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Guillain-Barré syndrome (GBS) has 
been described as adverse event follow-
ing different types of vaccines, such as in-
fluenza, varicella, polio virus and hepatitis 
B1. Since 2009 with the emergence of the 
pandemic H1N1 influenza virus infection 
in humans, new vaccines have been devel-
oped for influenza A (H1N1) as a preven-
tive strategy to reduce transmission, pro-
tect groups at increased risk of infection, 
and decrease complications and death2. In 
this context, we report two adults who de-
veloped GBS after H1N1 immunization.
CASES
Case 1
A previously healthy 33-year-old white 
man presented a 4-days history of progres-
sive and ascending numbness and tingling 
in his feet and legs, followed by weakness 
of his lower limbs. There was no sugges-
tive history of upper airway infection or 
diarrhea in the preceding weeks, but he 
had received H1N1 monovalent vaccine 
15 days before symptoms onset. Neuro-
logical examination disclosed superficial 
and profound sensibility diminished in 
the lower limbs, crural paraparesis (mus-
cle strength grade 4) and absent tendon 
reflexes. Laboratory work-up including 
complete blood count, TSH, tests for re-
nal and hepatic function, vitamin B12 and 
rheumatic screening were all normal. In-
fectious diseases screening (HIV, syphi-
lis, hepatitis, toxoplasmosis, cytomegalo-
virus, Epstein-bar and Campylobacter je-
juni) were negative. CSF analysis showed 
protein-cytological dissociation: 2 leuko-
cytes/mm3, protein 51mg/dL and normal 
glucose. Electrophysiological investigation 
was suggestive of acute demyelinating sen-
sory-motor polyneuropathy, more severe 
in the lower limbs. 
Case 2
A 23-year-old white man received the 
H1N1 monovalent vaccine and developed 
nonspecific symptoms as nausea, vomit-
ing, cramps and muscle pain. On seventh 
day, lower limb weakness was observed 
with mild distal sensory complaints. As-
cending weakness also affecting the upper 
limbs and respiratory insufficiency devel-
oped rapidly within 24 hours, requiring 
mechanical ventilation and he was trans-
ferred to the intensive care unit. Neuro-
logical examination showed flaccid tetra-
paresis with absent tendon reflexes in the 
four limbs. Laboratory studies were nega-
tive for infectious diseases and rheumat-
ic screening. Complete blood count, cre-
atinine, urea, glucose, TSH, B12 vitamin 
were all normal. A lumbar puncture was 
performed and CSF disclosed protein=69 
mg/dL with 2 leukocytes/mm3 and normal 
glucose. Treatment with intravenous im-
munoglobulin (0.4 g/kg per day, during 5 
days) resulted in weaning from ventilator 
and progressive motor improvement. Elec-
troneuromyography revealed absence of F 
waves and diffuse signs of demyelination, 
suggesting an acute inflammatory demy-
elinating polyneuropathy. 
DISCUSSION
GBS is usually preceded by an upper 
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airway respiratory or gastrointestinal infection. Although 
infrequent, it also may happen as a neurologic adverse 
event following immunization. The pathophysiology of 
vaccination-related GBS is not completely understood 
and probably an immune stimulation plays a role in its 
pathogenesis1,3.
Recent studies showed no conclusive result proving 
a causal relationship between influenza A vaccine and 
GBS, nor a possible increased risk for GBS after H1N1 
imunnization4,5. In this scenario, we cannot exclude that 
our patients had GBS as a coincidental finding, but the 
fact that no other secondary causes of GBS were found, 
and the symptoms of GBS developed very close to vacci-
nation should be considered. 
To summarize, our findings suggest a probably rela-
tionship between GBS and H1N1 monovalent vaccine. 
Further studies are necessary to unveil its real frequency 
and risk related to H1N1 immunization.
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